ENGN Logo

enGene Holdings Inc. Common Stock (ENGN) 

NASDAQ
Market Cap
$322.17M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
57 of 958
Rank in Industry
43 of 549

Largest Insider Buys in Sector

ENGN Stock Price History Chart

ENGN Stock Performance

About enGene Holdings Inc. Common Stock

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Insider Activity of enGene Holdings Inc. Common Stock

Over the last 12 months, insiders at enGene Holdings Inc. Common Stock have bought $8.07M and sold $0 worth of enGene Holdings Inc. Common Stock stock.

On average, over the past 5 years, insiders at enGene Holdings Inc. Common Stock have bought $8.07M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Forbion Growth Opportunities Fund I Cooperatief U.A. (10 percent owner) — $8.01M. Cooper Ronald Harold Wilfred (Chief Executive Officer) — $57,000.

The last purchase of 561,797 shares for transaction amount of $5M was made by Forbion Growth Opportunities Fund I Cooperatief U.A. (10 percent owner) on 2024‑10‑30.

List of Insider Buy and Sell Transactions, enGene Holdings Inc. Common Stock

2024-10-30Purchase10 percent owner
561,797
1.1339%
$8.90$5M-6.45%
2024-10-08Purchase10 percent owner
800
0.0012%
$6.60$5,278+18.31%
2024-10-07Purchase10 percent owner
11,844
0.0176%
$6.55$77,531+25.19%
2024-10-04Purchase10 percent owner
5,997
0.0089%
$6.54$39,242+25.94%
2024-10-03Purchase10 percent owner
5,769
0.0085%
$6.48$37,397+28.00%
2024-10-02Purchase10 percent owner
10,153
0.0147%
$6.37$64,697+28.33%
2024-10-01Purchase10 percent owner
35,279
0.0515%
$6.44$227,158+27.04%
2024-09-30Purchase10 percent owner
341,332
0.4906%
$6.34$2.16M+25.00%
2024-09-27Purchase10 percent owner
41,639
0.0564%
$5.97$248,699+35.29%
2024-09-27PurchaseChief Executive Officer
10,000
0.0129%
$5.70$57,000+35.29%
2023-12-29Purchase10 percent owner
10,020
0.0206%
$9.06$90,771-6.28%
2023-12-28Purchase10 percent owner
5,050
0.0088%
$7.69$38,827+6.66%
2023-12-27Purchase10 percent owner
2,750
0.0045%
$7.17$19,711+17.85%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.